CSS LLC’s Mereo BioPharma MREO Stock Holding History

CSS LLC’s Portfolio MREO Stock Details MREO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,735	Closed	-$7.59K	–	939
2023 Q1	$7.59K	Hold	10,735	–	–	﹤0.01%	681
2022 Q4	$8.05K	Hold	10,735	–	–	﹤0.01%	824
2022 Q3	$9K	Hold	10,735	–	–	﹤0.01%	972
2022 Q2	$12K	Hold	10,735	–	–	﹤0.01%	1019
2022 Q1	$12K	Hold	10,735	–	–	﹤0.01%	1098
2021 Q4	$17K	Hold	10,735	–	–	﹤0.01%	1189
2021 Q3	$26K	Hold	10,735	–	–	﹤0.01%	1120
2021 Q2	$34K	Hold	10,735	–	–	﹤0.01%	1015
2021 Q1	$36K	Sell	10,735 -4,000	-27%	-$14.1K	﹤0.01%	877
2020 Q4	$53K	Sell	14,735 -40,038	-73%	-$100K	﹤0.01%	758
2020 Q3	$144K	Hold	54,773	–	–	0.01%	615
2020 Q2	$168K	Sell	54,773 -20,000	-27%	-$35.3K	0.01%	505
2020 Q1	$78K	Buy	74,773 +22,574	+43%	+$39K	0.01%	512
2019 Q4	$171K	Sell	52,199 -26,008	-33%	-$66.5K	0.01%	520
2019 Q3	$233K	Buy	78,207 +1,055	+1%	+$3.19K	0.02%	425
2019 Q2	$195K	Buy	+77,152	New	+$337K	0.01%	447

Other funds holding MREO

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CSS LLC's MREO Position: Q2 2023 in Review

CSS LLC sold out of Mereo BioPharma (MREO) in Q2 2023, closing a stake of 10,735 shares — an estimated $7.59K sold.

CSS LLC first reported a position in MREO in Q2 2019 and held it in 16 quarters. The position peaked at $233K in Q3 2019. 53 funds tracked by Wall St. Rank hold MREO as of Q2 2023.

CSS LLC reported no remaining Mereo BioPharma position as of Q2 2023 after selling out during the quarter.
CSS LLC sold 10,735 Mereo BioPharma shares in Q2 2023, an estimated $7.59K.
CSS LLC first reported a position in Mereo BioPharma in Q2 2019 and held it in 16 quarters.
CSS LLC's Mereo BioPharma position peaked at $233K in Q3 2019.
53 funds tracked by Wall St. Rank held Mereo BioPharma as of Q2 2023.

Based on CSS LLC's 13F filing for Q2 2023, filed 14 Aug 2023.